chr3-20175019-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001199251.3(SGO1):āc.512T>Cā(p.Val171Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,585,702 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001199251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00795 AC: 1209AN: 152164Hom.: 14 Cov.: 32
GnomAD3 exomes AF: 0.00208 AC: 487AN: 234556Hom.: 6 AF XY: 0.00151 AC XY: 192AN XY: 126858
GnomAD4 exome AF: 0.000838 AC: 1201AN: 1433420Hom.: 17 Cov.: 31 AF XY: 0.000734 AC XY: 521AN XY: 710198
GnomAD4 genome AF: 0.00804 AC: 1224AN: 152282Hom.: 15 Cov.: 32 AF XY: 0.00831 AC XY: 619AN XY: 74466
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at